Estroven Weight Management
Natural health product licensed in Canada
- Licence holder
- i-Health Inc.
- NPN or DIN-HM
- 80067494
- Status
- Active licence
- Licence date
- 8 March 2016
- Revision date
- 13 July 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Actaea racemosa Source : Racine Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 240 milligramme | 40 milligramme | Not calculated |
| Cissus quadrangularis Source : Tige Potency : 2.5 % Keto-steroids | 300 milligramme | Not calculated |
| Cissus quadrangularis Source : Feuille Potency : 2.5 % Keto-steroids | 300 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 171:1 Dry plant equivalent : 23,940 milligramme Potency : 28 EAI Genistein | 140 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Potency : 56 EAI Isoflavones | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Phosphate dicalcique, Croscarmellose de sodium, Gélatine, Silice, Dioxyde de titane, Acide stéarique, Poudre de vanille, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Soy isoflavones may reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats). Black Cohosh helps relieve symptoms associated with menopause. Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management program. Contains proprietary Synetrim CQ / CQR-300 which supports cardiovascular health by reducing total LDL cholesterol. Synetrim CQ / CQR-300 helps to reduce blood glucose levels. Black Cohosh is used in Herbal Medicine to help ease nervous tension (calmative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80067494
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging